Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7102763 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL495924 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL2928747 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL494914 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL495661 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL494465 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL22612512 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL22612532 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL22612520 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 | |
| SCHEMBL493872 | 1.00 | TSHR (0.52) | TSHRLMNANFKB1PMP22FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3998084-A1 | CANCER CELL-TARGETED DRUG DELIVERY CARRIER AND COMPOSITION FOR PROMOTING PHOTO-THERMAL TREATMENT EFFECTS, BOTH OF WHICH CONTAIN M1 MACROPHAGES AS ACTIVE INGREDIENT | Korea University Research and Business Foundation (KR) | 2022-05-18 | — | — | EP | claimed |
| EP-3472301-A2 | CELL CULTURE DEVICE AND METHODS | Mimetas B.V. (NL) | 2019-04-24 | — | — | EP | claimed |
| WO-2017216113-A2 | CELL CULTURE DEVICE AND METHODS | MIMETAS B.V. (NL) | 2017-12-21 | — | — | WO | claimed |
| US-20160040126-A1 | REGULATION OF DIFFERENTIATION INTO DOPAMINERGIC NEURONS BY METALLOPROTEASE | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2016-02-11 | — | — | US | claimed |
| WO-2013125878-A1 | REGULATION OF DIFFERENTIATION INTO DOPAMINERGIC NEURONS BY METALLOPROTEASE | 고려대학교산학협력단 (KR) | 2013-08-29 | — | — | WO | claimed |
| WO-2009114522-A2 | COMPOSITIONS, KITS AND METHODS FOR DETERMINING ETIOLOGY OF TRALI AND DETECTING PATIENTS AT RISK FOR THIS TRANSFUSION REACTION | BONFILS BLOOD CENTER (US) | 2009-09-17 | — | — | WO | claimed |
| EP-1231220-B1 | Modified factor VIII cDNa and its use for the production of factor VIII | NEGRIER CLAUDE (FR) | 2009-05-13 | — | — | EP | claimed |
| EP-1315821-A2 | REPORTER SYSTEM FOR CELL SURFACE RECEPTOR-LIGAND BINDING | Owman, Christer S. D. (SE) | 2003-06-04 | — | — | EP | claimed |
| WO-2003008930-A2 | LFA-1 BINDING AGENTS THAT RECOGNIZE NEOEPITOPES | ICOS CORPORATION (US) | 2003-01-30 | — | — | WO | claimed |
| WO-2002020749-A2 | CHIMERIC REPORTER SYSTEM FOR CELL SURFACE RECEPTOR-LIGAND BINDING | OWMAN CHRISTER S O (SE) | 2002-03-14 | — | — | WO | claimed |
| US-6071889-A | INDUCING THE PROLIFERATION OF A MULTIPOTENT NEURAL STEM CELL COMPRISING A CULTURE MEDIUM SUPPLEMENTED WITH ATLEAST ONE GROWTH FACTROR, PREFERABLEY EPIDERAM GROWTH FACTOR OR TRANSFORMING GROWTH FACTOR ALPHA | NEUROSPHERES HOLDINGS LTD. (CA) | 2000-06-06 | — | — | US | claimed |
| EP-3883926-B1 | BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDE DERIVATIVES AND PROTEIN CONJUGATES THEREOF FOR USE AS LXR AGONISTS | REGENERON PHARMA (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024133857-A1 | AMIDINOUREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER | UNIVERSITE COTE D'AZUR (FR) | 2024-06-27 | — | — | WO | disclosed |
| CN-118223049-A | Micro-reaction process and system for electrolytically synthesizing musk ketone precursor by using circulating flow | 宏济堂制药(商河)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-114206906-B | PEGylated synthetic KL4 peptides, compositions and methods thereof | 香港大学 | 2024-02-20 | — | — | CN | disclosed |
| WO-1990007009-A1 | NOVEL LYMPHOKINE/CYTOKINE GENES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1990-06-28 | — | — | WO | disclosed |
| WO-1989002472-A1 | REGULATION OF EXPRESSION OF GM-CSF GENE | AMRAD CORPORATION LIMITED (AU) | 1989-03-23 | — | — | WO | disclosed |
| US-4800198-A | ANTITUMOR | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1989-01-24 | — | — | US | disclosed |
| EP-0269545-A1 | Food supplements containing a Vitamine E antioxidant activity simulator | BAR ILAN UNIVERSITY (IL) | 1988-06-01 | — | — | EP | disclosed |
| WO-1986006255-A1 | SECO-STEROL COMPOUNDS EFFECTIVE IN INDUCING THE DIFFERENTIATION OF MALIGNANT CELLS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1986-11-06 | — | — | WO | disclosed |